ORAL-CONTRACEPTIVES - THERAPEUTICS VERSUS ADVERSE REACTIONS, WITH AN OUTLOOK FOR FUTURE .2.

[1] ABELL C, 1968, J AM MED ASS, V203, P323

[2] ADAMS JH, 1970, LANCET, V2, P333

[3] ALLAN JS, 1967, FERTIL STERIL, V18, P112

[4] ARIAS IM, 1969, METABOLIC EFFECTS GO

[5] ARRATA WSM, 1972, AM J OBSTET GYNECOL, V112, P1025

[6] ARRATA WSM, 1972, J REPROD MED, V8, P139

[7] ARTHES FG, 1971, CANCER, V28, P1391, DOI 10.1002/1097-0142(197112)28:6<1391::AID-CNCR2820280609>3.0.CO

[8] 2-S

[9] BARTON G M G, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P551

[10] CLOMIPHENE [J]. BRITISH MEDICAL BULLETIN, 1970, 26 (01) : 22 - &

[1] ABELL C, 1968, J AM MED ASS, V203, P323

[2] ADAMS JH, 1970, LANCET, V2, P333

[3] ALLAN JS, 1967, FERTIL STERIL, V18, P112

[4] ARIAS IM, 1969, METABOLIC EFFECTS GO

[5] ARRATA WSM, 1972, AM J OBSTET GYNECOL, V112, P1025

[6] ARRATA WSM, 1972, J REPROD MED, V8, P139

[7] ARTHES FG, 1971, CANCER, V28, P1391, DOI 10.1002/1097-0142(197112)28:6<1391::AID-CNCR2820280609>3.0.CO

[8] 2-S

[9] BARTON G M G, 1970, Journal of Obstetrics and Gynaecology of the British Commonwealth, V77, P551

[10] CLOMIPHENE [J]. BRITISH MEDICAL BULLETIN, 1970, 26 (01) : 22 - &